Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
The intravenous medication, which should be used with standard antiretrovirals, has a wholesale acquisition cost of $118,000 per year.
With an FDA decision for ibalizumab pending, data about a group with multidrug resistance show that the antibody is effective.
TaiMed Biologics has applied for approval of the weekly injectable antibody ibalizumab for those with multidrug-resistant virus.
Theratechnologies has announced a major shortage of its drug Egrifta (tesamorelin, for injection), which reduces HIV-related excess belly fat.
Egrifta (tesamorelin) has been approved for the treatment of HIV-associated lipodystrophy, according to a November 10 announcement from...
A U.S. Food and Drug Administration (FDA) advisory committee has unanimously recommended that Egrifta (tesamorelin), Montreal-based...
FDA advisory panel is convening this week to decide whether to recommend approval of Egrifta, a belly fat-busting drug.
A U.S. Food and Drug Administration independent advisory committee is set to review Montreal-based Theratechnologies’ New Drug Application..
Montreal-based Theratechnologies announced yesterday that the U.S. Food and Drug Administration (FDA) will reschedule its meeting with...
In honor of World AIDS Day, AIDSmeds highlights the year’s top treatment stories.
If approved, tesamorelin will be sold in the United States by EMD Serono.
A new non-nuke, the apparent cure of an HIV-positive patient receiving a bone marrow transplant and the possibility of earlier...
The company also confirmed a proposed deal with EMD Serono to sell the drug in the United States once it is approved.
Theratechnologies announced today that it has sold the rights to sell the experimental lipodystrophy drug tesamorelin in the United StatesR...
Treatment with a tesamorelin resulted in a significant loss of visceral adipose tissue (VAT)—deep belly fat—compared with a placebo
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.